These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3907036)

  • 1. Enzyme-linked immunosorbent assay for serum renal tubular antigen in kidney transplant patients.
    Shen SY; Weir MR; Litkowski L; Anthony R; Welik R; Kosenko A; Light PD; Dagher FJ; Sadler JH
    Transplantation; 1985 Dec; 40(6):642-7. PubMed ID: 3907036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical graft evolution of lymphocytes, polymorphonuclear cells, and antigen expression in tubular renal cells in the urine sediment of 20 renal allograft recipients.
    Péfaur J; Triviño R; Navarrete C; Oberhauser E; Melys M; Morales I; Salinas P; Mocarquer A
    Transplant Proc; 2003 Nov; 35(7):2500-5. PubMed ID: 14611996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients.
    Schulak JA; Mayes JT; Moritz CE; Hricik DE
    Transplantation; 1990 Feb; 49(2):327-32. PubMed ID: 2407003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OKT3 treatment of steroid-resistant renal allograft rejection.
    Thistlethwaite JR; Gaber AO; Haag BW; Aronson AJ; Broelsch CE; Stuart JK; Stuart FP
    Transplantation; 1987 Feb; 43(2):176-84. PubMed ID: 3544373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of tubular injury in renal transplant patients by a urinary assay for a proximal tubular antigen, the adenosine-deaminase-binding protein.
    Tolkoff-Rubin NE; Cosimi AB; Delmonico FL; Russell PS; Thompson RE; Piper DJ; Hansen WP; Bander NH; Finstad CL; Cordon-Cardo C
    Transplantation; 1986 May; 41(5):593-7. PubMed ID: 2871646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients.
    Yoshimura N; Oka T; Kahan BD
    Transplantation; 1991 Jan; 51(1):172-6. PubMed ID: 1987687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum C-reactive protein concentrations in cyclosporine-treated renal allograft recipients.
    Cohen DJ; Benvenisty AI; Meyer E; Hardy MA
    Transplantation; 1988 May; 45(5):919-22. PubMed ID: 3285537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of cyclosporine weaning in renal transplantation.
    Loertscher R; Blier L; Steinmetz O; Nohr C
    Ann Surg; 1992 Apr; 215(4):368-76. PubMed ID: 1558418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma interleukin 2 receptor levels in renal allograft recipients.
    Colvin RB; Fuller TC; MacKeen L; Kung PC; Ip SH; Cosimi AB
    Clin Immunol Immunopathol; 1987 May; 43(2):273-6. PubMed ID: 3105939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay for urinary renal tubular antigen: a potential marker of tubular injury.
    Zager RA; Carpenter CB
    Kidney Int; 1978 Jun; 13(6):505-12. PubMed ID: 362038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reevaluation of T cell subset monitoring in cyclosporine-treated renal allograft recipients.
    Shen SY; Weir MR; Kosenko A; Revie DR; Ordonez JV; Dagher FJ; Chretien P; Sadler JH
    Transplantation; 1985 Dec; 40(6):620-3. PubMed ID: 3907032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor production during human renal allograft rejection is associated with depression of plasma protein C and free protein S levels and decreased intragraft thrombomodulin expression.
    Tsuchida A; Salem H; Thomson N; Hancock WW
    J Exp Med; 1992 Jan; 175(1):81-90. PubMed ID: 1309855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HLA-DR antigens on peripheral blood T lymphocytes and renal graft tubular epithelial cells in association with rejection.
    Henny FC; Weening JJ; Baldwin WM; Oljans PJ; Tanke HJ; van Es LA; Paul LC
    Transplantation; 1986 Nov; 42(5):479-83. PubMed ID: 3024368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G; Walsh G; Deshpande P; Koffman G
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection.
    Thistlethwaite JR; Cosimi AB; Delmonico FL; Rubin RH; Talkoff-Rubin N; Nelson PW; Fang L; Russell PS
    Transplantation; 1984 Dec; 38(6):695-701. PubMed ID: 6390834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.
    Kahan BD
    Lancet; 2000 Jul; 356(9225):194-202. PubMed ID: 10963197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
    Sandborn WJ; Hay JE; Porayko MK; Gores GJ; Steers JL; Krom RA; Wiesner RH
    Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.